You are here


July 31, 2014: Drs. David Scheinberg, Co-Chair of the Pharmacology PhD Program at Weill Cornell; Lucy Kappel, Regeneron; Barry Kappel, VP at CFRX; & Jimmy Rotolo, CFRX, ring the opening bell at NASDAQ! Lucy, Weill Cornell Immunology Program PhD, Barry & Jimmy, Pharmacology Program PhDs! CFRX is now listed on NASDAQ.

Weill Cornell Medicine Pharmacology 1300 York Avenue,
Room E-409
New York, NY 10021 Phone: (212) 746-6250 Fax: (212) 746-8835